At PharmaLegacy, data collection and reporting are incorporated into a premium database system BioBook (IDBS) which is Part 11 compliant. Data generated by specific functional groups are linked to the database and are reviewed by the lead scientists. Corrections to entries are electronically recorded automatically for quality assurance. Audited reports by our Quality Assurance Unit can be generated in a short time frame, when GLP status is required, to meet our clients filing schedules.